Serveur d'exploration Chloroquine - Curation (Istex)

Index « AbsEn.i » - entrée « rheumatic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
rheumaologists < rheumatic < rheumatism  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 71.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000001 (2011) Ilan Ben-Zvi [Israël] ; Shaye Kivity [Israël] ; Pnina Langevitz [Israël] ; Yehuda Shoenfeld [Israël]Hydroxychloroquine: From Malaria to Autoimmunity
000004 (1990) Susan Tett ; David Cutler ; Richard DayAntimalarials in rheumatic diseases
000037 (1982) R. O. Day ; P. Sambrook ; G. D. Champion ; G- G. GrahamAntimalarials in Rheumatic Diseases
000051 (1998) B. Lauren Charous ; Elkan F. Halpern ; Gary C. StevenHydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma
000074 (2006) A. Parke [États-Unis]Drug exposure, pregnancy outcome and fetal and childhood development occurring in the offspring of mothers with systemic lupus erythematosus and other chronic autoimmune diseases
000144 (2012) G. Key Er [Allemagne]Konventionelle Basistherapie der rheumatoiden Arthritis
000148 (2001) Monika Stensen [Suisse]Rheumatological disorders
000179 (2004) M. Motta [Italie] ; A. Tincani [Italie] ; A. Lojacono [Italie] ; D. Faden [Italie] ; R. Gorla [Italie] ; P. Air [Italie] ; F. Neri [Italie] ; A. Gasparoni [Italie] ; L. Ciardelli [Italie] ; A. De Silvestri [Italie] ; M. Marconi [Italie] ; G. Chirico [Italie]Neonatal outcome in patients with rheumatic disease
000220 (2012) Pramote Tragulpiankit [Thaïlande] ; Suvatna Chulavatnatol ; Ticha Rerkpattanapipat [Thaïlande] ; Suchela Janwityanujit [Thaïlande] ; Suthatip Somjarit ; Uamporn SirikhedgonAdverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients
000252 (2005) S. Bernatsky ; M. Hudson ; S. Suissa [Canada]Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis
000289 (2004) P. Jobanputra [Royaume-Uni] ; J. Wilson [Royaume-Uni] ; K. Douglas [Royaume-Uni] ; A. Burls [Royaume-Uni]A survey of British rheumatologists’ DMARD preferences for rheumatoid arthritis
000292 (1996) Jan BondesonEffects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines: a review
000315 (2009) Peter H Rle [Allemagne] ; Rainer H. Straub [Allemagne] ; Martin Fleck [Allemagne]Perioperative management of immunosuppression in rheumatic diseases—what to do?
000316 (1982) David Scott [Royaume-Uni] ; David Scott [Royaume-Uni] ; Paul Bacon [Royaume-Uni]THERAPEUTIC PROGRESS—REVIEW VITREATMENT OF RHEUMATOID ARTHRITIS
000345 (2012) Eamonn S. Molloy [Irlande (pays)] ; Leonard H. Calabrese [États-Unis]Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies
000389 (2000) R. Dinwiddie [Royaume-Uni]The lung in multi-system disease
000486 (2013) Mislav Radic [Croatie] ; Dusanka Martinovic Kaliterna [Croatie] ; Josipa Radic [Croatie]Overview of vasculitis and vasculopathy in rheumatoid arthritis—something to think about
000497 (1998) A. G. AeschlimannRheumatoid arthritis: current trends in conservative treatment
000517 (2001) Alexander Rozin [Israël] ; Daniel Schapira [Israël] ; Yolanda Braun-Moscovici [Israël] ; A. Menachem Nahir [Israël]Cotrimoxazole treatment for rheumatoid arthritis
000579 (2009) Deng-Ho Yang [République populaire de Chine] ; Deh-Ming Chang [République populaire de Chine] ; Jenn-Haung Lai [République populaire de Chine] ; Guo-Shu Huang [République populaire de Chine] ; Wei-Chou Chang [République populaire de Chine] ; Tsung-Yun Hou [République populaire de Chine, Niger]Remitting seronegative symmetrical synovitis with pitting edema following acute intracranial hemorrhage
000692 (2015) L. Cummins [Australie] ; V. S. Katikireddi [Australie] ; S. Shankaranarayana [Australie] ; K. Y. C. Su [Australie] ; E. Duggan [Australie] ; V. Videm [Australie, Norvège] ; H. Pahau [Australie] ; R. Thomas [Australie]Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "rheumatic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "rheumatic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    rheumatic
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021